A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in various types of cancer, https://madbookmarks.com/story21988764/mini-antibodies-revive-p53-new-potential-hope-for-malignant-therapy